ICD-10 Code | Description |
T43.211A | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter |
T43.211D | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), subsequent encounter |
T43.211S | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), sequela |
T43.212A | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter |
T43.212D | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, subsequent encounter |
T43.212S | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, sequela |
T43.213A | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter |
T43.213D | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, subsequent encounter |
T43.213S | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, sequela |
T43.214A | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter |
T43.214D | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, subsequent encounter |
T43.214S | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, sequela |
T43.215A | Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter |
T43.215D | Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter |
T43.215S | Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela |
T43.216A | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter |
T43.216D | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter |
T43.216S | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, sequela |